Liposomal curcumin for treatment of cancer
AssigneeBoard of Regents, The University of Texas System
InventorsRazelle Kurzrock, Lan Li, Kapil Mehta, Bharat Aggarawal
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Regents, The University of Texas System
InventorsRazelle Kurzrock, Lan Li, Kapil Mehta, Bharat Aggarawal
Estimating the term…
The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.
A method for the treatment or prevention of cancer in a mammalian subject, comprising:
A method for the treatment or prevention of cancer in a patient or other mammalian subject, comprising:
A composition for the treatment or prevention of cancer in a patient or other mammalian subject comprising curcumin, a curcumin analogue or a curcumin metabolite encapsulated in a colloidal drug delivery system.
A composition for the treatment or prevention of cancer in a patient or other mammalian subject comprising curcumin, a curcumin analogue or a curcumin metabolite encapsulated in a non-colloidal polymeric drug delivery system.
Dependencies are inferred from the claim text.